GM1 gangliosidosis is an autosomal recessive lysosomal storage disorder caused by mutations in the GLB1 gene, which codes for b-galactosidase. The incidence is estimated to be between 1 in 100 000 to 200 000 live births. Type I is the most severe form and results in neurologic impairment caused by accumulation of GM1 gangliosides, typically within the first 6 months of life. Other features include a macular cherry-red spot, coarse facies, and hepatosplenomegaly. Vacuolated lymphocytes and eosinophils with abnormally sparse and enlarged granules are characteristic findings in the peripheral smear. Supportive care is typically given, because there is no effective treatment of the underlying disorder.
